Associate Professor
Simpa Salami’s global work focuses on early detection and staging of prostate and kidney cancer. He seeks to leverage novel imaging, machine learning, and next generation sequencing approaches at a global scale. His interests in global health equity align with the Center themes of strengthening systems for health and providing technical solutions. Salami’s main research goal is to develop liquid and tissue-based biomarkers and elucidate optimal paradigms for early detection of prostate and kidney cancer.
